- Home
- TCRX vs DCGO Comparison
TCRX vs DCGO Comparison
Compare TCRX & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- DCGO
- Stock Information
- Founded
- TCRX 2018
- DCGO 2015
- Country
- TCRX United States
- DCGO United States
- Employees
- TCRX N/A
- DCGO N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- DCGO Managed Health Care
- Sector
- TCRX Health Care
- DCGO Health Care
- Exchange
- TCRX Nasdaq
- DCGO Nasdaq
- Market Cap
- TCRX 140.7M
- DCGO 136.0M
- IPO Year
- TCRX 2021
- DCGO N/A
- Fundamental
- Price
- TCRX $1.92
- DCGO $1.08
- Analyst Decision
- TCRX Strong Buy
- DCGO Strong Buy
- Analyst Count
- TCRX 5
- DCGO 3
- Target Price
- TCRX $9.40
- DCGO $3.37
- AVG Volume (30 Days)
- TCRX 648.1K
- DCGO 4.3M
- Earning Date
- TCRX 11-07-2025
- DCGO 11-10-2025
- Dividend Yield
- TCRX N/A
- DCGO N/A
- EPS Growth
- TCRX N/A
- DCGO N/A
- EPS
- TCRX N/A
- DCGO N/A
- Revenue
- TCRX $6,961,000.00
- DCGO $435,968,564.00
- Revenue This Year
- TCRX $255.18
- DCGO N/A
- Revenue Next Year
- TCRX N/A
- DCGO N/A
- P/E Ratio
- TCRX N/A
- DCGO N/A
- Revenue Growth
- TCRX N/A
- DCGO N/A
- 52 Week Low
- TCRX $1.02
- DCGO $1.05
- 52 Week High
- TCRX $6.23
- DCGO $5.68
- Technical
- Relative Strength Index (RSI)
- TCRX 41.52
- DCGO 37.32
- Support Level
- TCRX $2.23
- DCGO $1.11
- Resistance Level
- TCRX $2.43
- DCGO $1.65
- Average True Range (ATR)
- TCRX 0.19
- DCGO 0.11
- MACD
- TCRX -0.04
- DCGO -0.01
- Stochastic Oscillator
- TCRX 1.52
- DCGO 4.98
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.